Immunophotonics
PrivateLast Round
Series C
Sep 1, 2026
Total Funding Raised
$29.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Immunophotonics is a biotechnology company that develops novel immunostimulatory drugs designed to enhance routine tumor destruction treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunophotonics Comparables
Compare Immunophotonics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rampart Health | 84% | |
| Syncromune, Inc. | 83% | |
| Highlight Therapeutics | 80% | |
Immunophotonics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 1, 2026 | ||||
| Debt | Feb 29, 2024 | ||||
| Grant | Oct 25, 2022 | ||||
| Series B | Apr 6, 2022 | ||||
| Grant | Feb 17, 2022 | ||||
Series A | Sep 3, 2014 |
Key People
Founding team and executive leadership
Immunophotonics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Zubizoom Investments | Series B |
| iSelect Fund | Series B |
| Arch Grants | Grant |
| Cultivation Capital | Series A |
| Missouri Technology Corporation | Series A |
| St. Louis Arch Angels | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
$10M round raised.
- Apr 18, 2026
Monthly visitors grew 58% MoM, reaching 2.6K.
Immunophotonics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immunophotonics's valuation, stock price, and market status.